サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1452517

アジア太平洋の急性膵炎：2030年までの市場予測 - 地域別分析 - 提供別、病因別、エンドユーザー別

Asia Pacific Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 106 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
アジア太平洋の急性膵炎：2030年までの市場予測 - 地域別分析 - 提供別、病因別、エンドユーザー別
出版日: 2023年12月22日
発行: The Insight Partners
ページ情報: 英文 106 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の急性膵炎市場は、2022年に6億735万米ドルと評価され、2030年には10億7,606万米ドルに達すると予測され、2022年から2030年までのCAGRは7.4%で成長すると予測されています。

急性膵炎に関する研究開発活動と啓発プログラムの増加がアジア太平洋の急性膵炎市場を後押し

急性膵炎の病因、経過、治療法を調査するため、世界的に広範な研究が行われています。国立膵臓財団（NPF）は、1プロジェクトあたり～US$50,000相当の複数の調査助成金を提供しています。現在までに、NPFは133の画期的な研究プロジェクトに500万米ドル以上を提供しています。助成金は、膵炎、膵臓がん、小児膵炎の診断および／または治療のために1年間授与されます。

さらに、急性膵炎の疫学と病態生理学を明らかにするために、いくつかの国際的な努力が続けられています。従って、アジア太平洋の急性膵炎市場の企業にとって、（直接的・間接的な手段による）効果的な治療法開拓のための急性膵炎に関する研究開発活動や啓発プログラムは、非常に実り多いものになると予想されます。

アジア太平洋の急性膵炎市場概要

アジア太平洋の急性膵炎市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋に区分されます。市場開拓の背景には、膵炎患者の増加、膵炎の治療法を開発する研究者、国民の意識を高めるための政府の取り組みなどがあります。さらに、アルコールに関連した膵炎の症例も同地域の市場成長を後押ししています。中国では近年、膵炎の有病率が上昇傾向を示しています。2022年に発表された「Burden of Pancreatitis and associated risk factors in China, 1990 to 2019」と題する研究によると、同国では近年、アルコール摂取が膵炎の疾病負担における重要な病因となっています。中国では、アルコール性膵炎の症例は10年前と比べて著しく増加しています。同国では、膵炎患者数は1990年に380,018人、2019年に493,765人でした。1990年から2019年にかけて、膵炎による死亡者数も増加し、1990年には8,976人、2019年には10,664人を占めました。2019年、アルコール関連膵炎による死亡者数は国内で3,327.29人であり、膵炎による死亡者総数の31.20％を占めています。

アジア太平洋の急性膵炎市場の収益と2030年までの予測（US$Mn）

アジア太平洋の急性膵炎市場のセグメンテーション

アジア太平洋の急性膵炎市場は、提供、病因、エンドユーザー、国別にセグメント化されています。

提供物に基づき、アジア太平洋の急性膵炎市場は投薬、診断、その他に区分されます。診断セグメントが2022年に最大の市場シェアを占めました。

方法に基づき、アジア太平洋の急性膵炎市場は胆石、アルコール中毒、遺伝性疾患、感染症、その他に区分されます。胆石セグメントは2022年に最大の市場シェアを占めました。

エンドユーザー別では、アジア太平洋の急性膵炎市場は病院、診断研究所、外来手術センター、その他に分けられます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、アジア太平洋の急性膵炎市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。中国は、2022年のアジア太平洋の急性膵炎市場を独占しました。

Abbott Laboratories、Baxter International Inc、Boston Scientific Corp、Dynavax Technologies Corp、Fresenius Kabi AG、GE HealthCare Technologies Inc、Koninklijke Philips NV、Medtronic Plc、Samsung Healthcareは、アジア太平洋の急性膵炎市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • アジア太平洋の急性膵炎市場：国別

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の急性膵炎市場情勢

第5章 アジア太平洋の急性膵炎市場-主要産業力学

  • 主な市場促進要因
    • 急性膵炎による膵がん患者の増加
    • 急性膵炎後の糖尿病罹患率の上昇
  • 主な市場抑制要因
    • 膵炎および膵がん治療の副作用
  • 主な市場機会
    • 急性膵炎に関する研究開発活動および啓発プログラムの増加
  • 今後の動向
    • 特定の急性膵炎治療の進歩
  • 影響分析

第6章 急性膵炎市場-アジア太平洋市場分析

  • アジア太平洋の急性膵炎市場収益、2022年～2030年

第7章 アジア太平洋の急性膵炎市場：収益と2030年までの予測：提供別

  • 市場収益シェア（2022年・2030年）
  • 薬物療法
  • 診断
  • その他

第8章 アジア太平洋の急性膵炎市場：収益と2030年までの予測：病因別

  • 市場収益シェア（2022年・2030年）
  • 胆石症
  • アルコール中毒
  • 遺伝性疾患
  • 感染症
  • その他

第9章 アジア太平洋の急性膵炎市場：収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア（2022年・2030年）
  • 病院
  • 診断研究所
  • 外来手術センター
  • その他

第10章 アジア太平洋の急性膵炎市場：国別分析

  • アジア太平洋の急性膵炎市場：国別
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋

第11章 アジア太平洋の急性膵炎市場-業界情勢

  • アジア太平洋の急性膵炎市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • GE HealthCare Technologies Inc
  • Samsung Healthcare
  • Koninklijke Philips NV
  • Baxter International Inc
  • Dynavax Technologies Corp
  • Fresenius Kabi AG
  • Medtronic Plc
  • Boston Scientific Corp

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Acute Pancreatitis Market Segmentation
  • Table 2. Asia Pacific Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Asia Pacific Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. China: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. China: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Japan: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Japan: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Japan: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Japan: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. India: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. India: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. India: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. India: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. India: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Australia: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Australia: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Australia: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Australia: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Australia: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. South Korea: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. South Korea: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. South Korea: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. South Korea: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. South Korea: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Recent Inorganic Growth Strategies in the Asia Pacific Acute Pancreatitis Market
  • Table 35. Recent Organic Growth Strategies in the Asia Pacific Acute Pancreatitis Market
  • Table 36. Glossary of Terms, Asia Pacific Acute Pancreatitis Market

List Of Figures

  • Figure 1. Asia Pacific Acute Pancreatitis Market Segmentation, By Country
  • Figure 2. Asia Pacific Acute Pancreatitis Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
  • Figure 6. Medications: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Diagnosis: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Asia Pacific Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
  • Figure 10. Gallstones: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Alcoholism: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Genetic Disorders: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Infections: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Asia Pacific Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 16. Hospitals: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Diagnostic Laboratories: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Ambulatory Surgical Centers: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 21. Asia Pacific Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
  • Figure 22. China: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. Japan: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. India: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Australia: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. South Korea: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Growth Strategies in the Asia Pacific Acute Pancreatitis Market
目次
Product Code: BMIRE00029216

The Asia Pacific acute pancreatitis market was valued at US$ 607.35 million in 2022 and is expected to reach US$ 1,076.06 million by 2030; it is estimated to grow at a CAGR of 7.4% from 2022 to 2030.

Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis Fuels the Asia Pacific Acute Pancreatitis Market

Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis.

Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the Asia Pacific acute pancreatitis market.

Asia Pacific Acute Pancreatitis Market Overview

The Asia Pacific acute pancreatitis market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The market growth is attributed to factors including rising cases of pancreatitis, researchers to develop a treatment for pancreatitis, and government efforts to raise awareness among the population. In addition, alcohol-related pancreatitis cases also fuel the growth of the market in the region. The prevalence of pancreatitis has shown an upward trend in recent years in China. According to a study titled "Burden of Pancreatitis and associated risk factors in China, 1990 to 2019," published in 2022, alcohol consumption has become an important cause in the disease burden of pancreatitis in recent years in the country. In China, cases of alcoholic pancreatitis are significantly higher compared to 10 years ago. In the country, the number of pancreatitis cases was 380,018 in 1990 and 493,765 in 2019. From 1990 to 2019, the total number of deaths due to pancreatitis also increased, accounting for 8,976 in 1990 and 10,664 in 2019. In 2019, the number of deaths due to alcohol-related pancreatitis was 3,327.29 in the country, accounting for 31.20% of the total deaths due to pancreatitis.

Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Asia Pacific Acute Pancreatitis Market Segmentation

The Asia Pacific acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the Asia Pacific acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on method, the Asia Pacific acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the Asia Pacific acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific acute pancreatitis market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific acute pancreatitis market in 2022.

Abbott Laboratories, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Asia Pacific acute pancreatitis market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Asia Pacific Acute Pancreatitis Market, by Country (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Acute Pancreatitis Market Landscape

  • 4.1 Overview

5. Asia Pacific Acute Pancreatitis Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
    • 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
  • 5.2 Key Market Restraints
    • 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
  • 5.3 Key Market Opportunities
    • 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
  • 5.4 Future Trends
    • 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
  • 5.5 Impact Analysis:

6. Acute Pancreatitis Market - Asia Pacific Market Analysis

  • 6.1 Asia Pacific Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

  • 7.1 Overview
  • 7.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
  • 7.3 Medications
    • 7.3.1 Overview
    • 7.3.2 Medications: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 Asia Pacific Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
  • 7.4 Diagnosis
    • 7.4.1 Overview
    • 7.4.2 Diagnosis: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 Asia Pacific Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

  • 8.1 Overview
  • 8.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
  • 8.3 Gallstones
    • 8.3.1 Overview
    • 8.3.2 Gallstones: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Alcoholism
    • 8.4.1 Overview
    • 8.4.2 Alcoholism: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genetic Disorders
    • 8.5.1 Overview
    • 8.5.2 Genetic Disorders: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Infections
    • 8.6.1 Overview
    • 8.6.2 Infections: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Ambulatory Surgical Centers
    • 9.5.1 Overview
    • 9.5.2 Ambulatory Surgical Centers: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Asia Pacific Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Acute Pancreatitis Market - Country Analysis

  • 10.1 Overview
      • 10.1.1.1 Asia Pacific Acute Pancreatitis Market, by Country
      • 10.1.1.2 China
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 China: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 China: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.2.3.1 China: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.2.3.2 China: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.2.4 China: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.2.5 China: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Japan
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Japan: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Japan: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.3.3.1 Japan: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.3.3.2 Japan: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Japan: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Japan: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.4 India
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 India: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 India: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.4.3.1 India: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.4.3.2 India: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.4.4 India: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.4.5 India: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.5 Australia
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Australia: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.3 Australia: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.5.3.1 Australia: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.5.3.2 Australia: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.5.4 Australia: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.5.5 Australia: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.6 South Korea
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 South Korea: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.3 South Korea: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.6.3.1 South Korea: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.6.3.2 South Korea: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.6.4 South Korea: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.6.5 South Korea: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.7 Rest of Asia Pacific
        • 10.1.1.7.1 Overview
        • 10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.7.3.1 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Medications by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.7.3.2 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, For Diagnosis by Offerings, 2020-2030 (US$ Million)
        • 10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by Causes, 2020-2030 (US$ Million)
        • 10.1.1.7.5 Rest of Asia Pacific: Asia Pacific Acute Pancreatitis Market, by End User, 2020-2030 (US$ Million)

11. Asia Pacific Acute Pancreatitis Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Asia Pacific Acute Pancreatitis Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 GE HealthCare Technologies Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Samsung Healthcare
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Koninklijke Philips NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Baxter International Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Dynavax Technologies Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Fresenius Kabi AG
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Boston Scientific Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms